Jeff Yass’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
Other funds holding VIR
Jeff Yass's VIR Position: Q3 2026 in Review
Jeff Yass increased its Vir Biotechnology (VIR) stake by 527% in Q3 2026, buying an estimated $1.95M and bringing the position to 231,879 shares worth $2.59M. The position accounts for ﹤0.01% of the portfolio, ranked #5712.
Jeff Yass first reported a position in VIR in Q1 2020 and has held it in 27 quarters since. The position peaked at $8.8M in Q1 2022. 264 funds tracked by Wall St. Rank hold VIR as of Q3 2026.
- Jeff Yass held 231,879 shares of Vir Biotechnology worth $2.59M as of Q3 2026.
- Jeff Yass bought 194,895 Vir Biotechnology shares in Q3 2026, an estimated $1.95M.
- Vir Biotechnology made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #5712 holding.
- Jeff Yass first reported a position in Vir Biotechnology in Q1 2020 and has held it in 27 quarters since.
- Jeff Yass's Vir Biotechnology position peaked at $8.8M in Q1 2022.
- 264 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.